Literature DB >> 15930777

Synthesis and evaluation of beta-carbolinium cations as new antimalarial agents based on pi-delocalized lipophilic cation (DLC) hypothesis.

Kiyosei Takasu1, Tsubasa Shimogama, Chalerm Saiin, Hye-Sook Kim, Yusuke Wataya, Reto Brun, Masataka Ihara.   

Abstract

Several beta-carbolines including naturally occurring substances and their corresponding cationic derivatives were synthesized and evaluated for antimalarial (antiplasmodial) activity in vitro and in vivo. A tetracyclic carbolinium salt was elucidated for antileishmanial and antitrypanosomal activities in vitro as well as antiplasmodial activity. Quarternary carbolinium cations showed much higher potencies in vitro than electronically neutral beta-carbolines and a good correlation was observed between pi-delocalized lipophilic cationic (DLC) structure and antimalarial efficacy. beta-Carbolinium compounds exhibit medium suppressive activity in vivo against rodent malaria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930777     DOI: 10.1248/cpb.53.653

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  2-N-Methyl modifications and SAR studies of manzamine A.

Authors:  Mohamed A Ibrahim; Abbas G Shilabin; Sivaprakasam Prasanna; Melissa Jacob; Shabana I Khan; Robert J Doerksen; Mark T Hamann
Journal:  Bioorg Med Chem       Date:  2008-06-05       Impact factor: 3.641

Review 2.  Methylene blue and its analogues as antidepressant compounds.

Authors:  Anzelle Delport; Brian H Harvey; Anél Petzer; Jacobus P Petzer
Journal:  Metab Brain Dis       Date:  2017-07-31       Impact factor: 3.584

3.  SAHAquines, Novel Hybrids Based on SAHA and Primaquine Motifs, as Potential Cytostatic and Antiplasmodial Agents.

Authors:  Maja Beus; Zrinka Rajić; Dusica Maysinger; Zvonimir Mlinarić; Maja Antunović; Inga Marijanović; Diana Fontinha; Miguel Prudêncio; Jana Held; Sureyya Olgen; Branka Zorc
Journal:  ChemistryOpen       Date:  2018-08-21       Impact factor: 2.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.